
Receptor
North America, New York, United States, New York
Description
Investing in the future of psychedelic medicine.
Investor Profile
Receptor has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Pre Seed rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.
Stage Focus
- Seed (67%)
- Pre Seed (33%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Life Science
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.